NCT03106766

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

A Single-center, Double-blind, Controlled Study to Evaluate the Effect of Next Science™ Acne Cream on Mild to Moderate Facial Acne in Adult Females Over 6 Months.

• Status: Terminated
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 2 (actual)
• Sponsor: Next Science TM · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To assess facial acne vulgaris clinical and psychological outcomes by measuring differences in lesions counts, investigator global assessment, and subjects quality of life scores over 6 months in adult females treated with Next Science™ acne cream 2x or Next Science™ acne cream 1x in a double blind manner.

Detailed description

This is a 6-month, single-site, double-blind, controlled study in 20 female subjects with mild to moderate facial acne. Subjects will be randomized 1:1 to apply either topical Next Science™ acne cream 2x or Next Science™ acne cream 1x daily. Subjects will be evaluated for clinical acne and quality of life outcomes at baseline, 6, 12, 18 and 24 weeks.

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	Acne cream 2X	Twice daily application of facial acne cream 2X after facial cleansing
DRUG	Acne cream 1X	Twice daily application of facial acne cream 1X after facial cleansing

Timeline

• Start date: 2017-03-27
• Primary completion: 2017-08-14
• Completion: 2017-08-14
• First posted: 2017-04-10
• Last updated: 2017-08-30

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study